pubmed.ncbi.nlm.nih.gov

High-mobility group box 1 and cancer - PubMed

Review

High-mobility group box 1 and cancer

Daolin Tang et al. Biochim Biophys Acta. 2010 Jan-Feb.

Abstract

High-mobility group box 1 protein (HMGB1), a chromatin associated nuclear protein and extracellular damage associated molecular pattern molecule (DAMP), is an evolutionarily ancient and critical regulator of cell death and survival. Overexpression of HMGB1 is associated with each of the hallmarks of cancer including unlimited replicative potential, ability to develop blood vessels (angiogenesis), evasion of programmed cell death (apoptosis), self-sufficiency in growth signals, insensitivity to inhibitors of growth, inflammation, tissue invasion and metastasis. Our studies and those of our colleagues suggest that HMGB1 is central to cancer (abnormal wound healing) and many of the findings in normal wound healing as well. Here, we focus on the role of HMGB1 in cancer, the mechanisms by which it contributes to carcinogenesis, and therapeutic strategies based on targeting HMGB1.

Copyright 2009 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Intranuclear and Extranuclear Functions of HMGB1

The high-mobility group box 1 protein (HMGB1) is present in almost all metazoans and plants. The expression of HMGB1 is regulated by transcription factors including p53, c-Myc, and KLF4 in individual cell types. As a DNA chaperone, HMGB1 participates in DNA replication, recombination, transcription and repair. HMGB1 also been interacts with and enhances the activities of a number of transcription factors implicated in cancer development, including p53, p73, the retinoblastoma protein (RB), members of the Rel/NF-κB family, and nuclear hormone receptors including the estrogen receptor (ER). Cytosolic HMGB1 promotes autophagy and, in particular, mitophagy. HMGB1 is passively released from necrotic cells and is actively secreted by inflammatory cells, binding with high affinity to several receptors including the receptor for advanced glycation end products (RAGE), Toll-like receptors (TLR)-2, TLR-4, TLR-9, and, as a negative signaling molecule, CD24, mediating the response to infection, immunity, autoimmunity, chemotaxis, cell proliferation and tissue regeneration.

Figure 2
Figure 2. Role of HMGB1 in Cancer

In cancer, overexpression of HMGB1 is associated with each of the hallmarks of cancer including unlimited replicative potential, ability to develop blood vessels (angiogenesis), evasion of programmed cell death (apoptosis), self-sufficiency in growth signals, insensitivity to inhibitors of growth, inflammation, tissue invasion and metastasis.

Similar articles

Cited by

References

    1. Goodwin GH, Johns EW. The isolation and purification of the high mobility group (HMG) nonhistone chromosomal proteins. Methods Cell Biol. 1977;16:257–267. - PubMed
    1. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331–342. - PubMed
    1. Muller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A, Beltrame M, Bianchi ME. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. Embo J. 2001;20:4337–4340. - PMC - PubMed
    1. Dong XD, Ito N, Lotze MT, Demarco RA, Popovic P, Shand SH, Watkins S, Winikoff S, Brown CK, Bartlett DL, Zeh HJ., 3rd High Mobility Group Box I (HMGB1) Release From Tumor Cells After Treatment: Implications for Development of Targeted Chemoimmunotherapy. J Immunother (1997) 2007;30:596–606. - PubMed
    1. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res. 2007;13:2836–2848. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources